NCT05624268Phase 3Completed

Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD

Study sponsor: COMPASS Pathways

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2025-05-28Actual
Enrollment · participants258Actual
Source updated2026-08-10Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 3 fields changed

Participant count type changed

− Before

Estimated

+ After

Actual

Enrollment · participant count changed

− Before

255 participants (planned)

+ After

258 participants (actual)

Recruitment status changed

− Before

Active not recruiting

+ After

Completed

Check registry source